ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 177 filers reported holding ACCELERON PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $224,000 | -25.8% | 5,146 | -2.5% | 0.00% | -25.0% |
Q3 2018 | $302,000 | +37.3% | 5,278 | +16.3% | 0.00% | +33.3% |
Q2 2018 | $220,000 | +24.3% | 4,537 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $177,000 | -10.6% | 4,537 | -2.7% | 0.00% | 0.0% |
Q4 2017 | $198,000 | -1.5% | 4,662 | -13.3% | 0.00% | 0.0% |
Q3 2017 | $201,000 | +45.7% | 5,376 | +18.4% | 0.00% | +50.0% |
Q2 2017 | $138,000 | +6.2% | 4,539 | -7.3% | 0.00% | 0.0% |
Q1 2017 | $130,000 | -4.4% | 4,897 | -8.0% | 0.00% | -33.3% |
Q4 2016 | $136,000 | -77.1% | 5,320 | -67.6% | 0.00% | -70.0% |
Q3 2016 | $594,000 | +6.6% | 16,400 | 0.0% | 0.01% | -9.1% |
Q2 2016 | $557,000 | +28.6% | 16,400 | 0.0% | 0.01% | +37.5% |
Q1 2016 | $433,000 | -45.9% | 16,400 | 0.0% | 0.01% | -42.9% |
Q4 2015 | $800,000 | +79.8% | 16,400 | -8.2% | 0.01% | +100.0% |
Q3 2015 | $445,000 | -59.8% | 17,860 | -49.0% | 0.01% | -12.5% |
Q2 2015 | $1,108,000 | +177.0% | 35,000 | +233.3% | 0.01% | +33.3% |
Q1 2015 | $400,000 | -2.2% | 10,500 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $409,000 | +31.1% | 10,500 | 0.0% | 0.01% | +20.0% |
Q3 2014 | $312,000 | – | 10,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |